Legal Document View

Unlock Advanced Research with PRISMAI

- Know your Kanoon - Doc Gen Hub - Counter Argument - Case Predict AI - Talk with IK Doc - ...
Upgrade to Premium
[Cites 43, Cited by 0]

Himachal Pradesh High Court

Decided On: July 4 vs State Of Himachal Pradesh And Others on 4 July, 2024

Author: Sandeep Sharma

Bench: Sandeep Sharma

                                                                                        2024:HHC:4799
             IN THE HIGH COURT OF HIMACHAL PRADESH, SHIMLA.
                                              CrMMO No. 738 of 2021
                                             Decided on: July 4, 2024




                                                                                .
    ________________________________________________________





    Anil Mediratta and others                      ...........Petitioners
                                      Versus
    State of Himachal Pradesh and others             ....Respondents
    ________________________________________________________





    Coram:
    Hon'ble Mr. Justice Sandeep Sharma, Judge.
    Whether approved for reporting? 1yes.
    ________________________________________________________

    For the Petitioners                    :      Mr. Anand Sharma, Senior Advocate





                                                  with Mr. Karan Sharma, Advocate.

    For the Respondents                    :      Mr. Rajan Kahol, Mr. Vishal Panwar
                                                  and Mr. B.C. Verma, Additional
                        r                         Advocates General with Mr. Ravi
                                                  Chauhan, Deputy Advocate General,

                                                  for respondent No.1.

                                                  None for respondents Nos. 2 to 6.

                               Mr. Sunny Rawat, Advocate, for


                               respondent No.7.
    ________________________________________________________

    Sandeep Sharma, Judge (oral):

By way of instant petition filed under S.482 CrPC, prayer has been made on behalf of the petitioners herein for quashing of complaint No. HFW-HMR(PROS) DRUGS/10-09, registered as Complaint No. 58-1 of 2010 titled as State of Himachal Pradesh (through Drugs Inspector H.Q. Hamirpur) v. Anil Chand and others (Annexure P-2) as well as consequent proceedings pending in the court of learned Judicial Magistrate First Class, Nadaun, Hamirpur.

2. For having bird's eye view of the matter, facts relevant for adjudication of the case at hand are that on 8.1.2009 Drug Inspector, 1 Whether the reporters of the local papers may be allowed to see the judgment?

::: Downloaded on - 09/07/2024 20:31:53 :::CIS 2

Headquarters, Hamirpur alongwith Shri Jagdish Chand, Peon, visited premises of co-accused /respondent No. 2 Anil Chand Pharmacist, in-

.

cahge of M/s Shri Shri Medical Store, Opposite Bus Stand Nadaun, District Hamirpur, Himachal Pradesh. Drug Inspector concerned after having noticed that said Anil Chand was conducting business of stocking and exhibiting for sale of allopathic drugs over the counter via his retail drugs licence No. HMR/2006/389 and HMR/2006/390 valid upto 29.3.2011, picked up three samples of drug namely Chlorpheniramine Maleate Tablets (C.P. Sys-4) B. No. LGT-8106, expiry date 08/2011, manufactured by M/s Legen Healthcare, Plot No.20, Sector 05, Parwanoo, District Solan, Himachal Pradesh. As per procedure, aforesaid drug was sent for chemical examination to C.T.L. Kandaghat. However, vide report dated 31.10.2009 (annexed with the complaint) sample of aforesaid Chlorpheniramine Maleate was "not of standard quality as defined in the Drugs and Cosmetics Act, 1940 and Rules there under" for the reason that "the sample of Chlorpheniramine Maleate tablets contained less content of Chlorpheniramine Maleate i.e. 37.25 % against the prescribed limit i.e. 95% to 105% as per I.P."(available page 96 of paper book).

3. After receipt of aforesaid 'adverse' analysis report, (AnnexureP-

J), Drug Inspector concerned, vide letter dated 9.11.2009, sent a communication to Anil Chand, Pharmacist respondent No.2, (Annexure P-J1) In Charge M/s Shri Shri Medical Store to disclose the information as required under S.18-A of the Act, who in turn, vide his reply, (Annexure PJ2) disclosed that the said drug was purchased by him ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 3 from M/s Aar Kay Surgicals Tibhra Road, Sujanpur, Village and Post Office Sujanpur, District Hamirpur, vide invoice No. AKV=-908 dated .

23.12.2008 (Annexure PJ3 of complaint). Drug Inspector concerned, issued letter dated 2.12.2009 to M/s Aar Kay Surgicals, Sujanpur alongwith enclosing therewith copy of adverse analysis report and purchase invoice, asking it to disclose the information as required under S.18-A of the Act, who in turn vide letter dated 9.12.2009, (Annexure PK2 of complaint) disclosed that the drug in question was purchased by it from M/s Generica India Limited, 718, 719, Main Burari Road, Burari, Delhi vide invoice No. GIO-2530, dated 21.10.2008 (Annexure PK4 of complaint). Said firm also informed vide letter 9.12.2009 that drug was received by it from authorized signatory of the said firm, namely Mr. Hem Raj Thakur.

4. In the aforesaid background, Drug Inspector sent a notice to M/s Generica India Limited on 17.12.2009 (Annexure PL of complaint) with a copy of Adverse Analysis Report and related copies of purchase invoices, asking it to disclose the information as required under S.18-A of the Act. M/s Generica India Limited vide letter dated 23.12.2009 (Annexure PM of complaint) disclosed that the said drug was purchasd by it from M/s Legen Healthcare, Plot No. 20, Sector 05, Parwanoo, District Solan, Himachal Pradesh vide invoice No. 4, dated 7.10.2008.

(Annexure PM1 of complaint). (page 136, 139 of paper book).

5. On the basis of information shared by M/s Legen Healthcare, which had allegedly manufactured the drug in question, Drug Inspector issued letter dated 1.2.2010 (Annexure PN of complaint) enclosing ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 4 therewith sealed sample portion and it was asked to disclose the information as required under S.18-A of the Act. Said company issued .

letter dated 10.2.2010 stating that it was not satisfied with report of CTL Kandaghat and requested to send the second sample for re-testing to Central Drug Laboratory. Though aforesaid prayer made by M/s Legen Healthcare was not acceded to but Drug Inspector having found breach of provisions of the Act, filed a complaint in the competent court of law (Annexure P-2, page 58) inter alia impleading petitioners herein, as

6.

r to accused Nos. 5 to 7, who happen to be Directors of M/s Generica India Limited.

Taking cognizance of averments contained in the complaint and documents annexed therewith, learned trial Court issued process against the accused named in the complaint, including the petitioners, however, fact remains that the complaint is still pending adjudication.

7. Initially, one of the partners of M/s Legen Healthcare, namely Ashish Mittal (Accused No. 11) had approached this court by way of CrMMO No. 111 of 2013, titled Ashish Mittal v. Shri Anil Chand and others for quashing of proceedings. On account of pendency of aforesaid petition, proceedings in the complaint filed by Drug Inspector could not proceed further. On account of judgment dated 16.9.2013 passed by Co-ordinate Bench of this Court in CrMMO No. 111 of 2013, Ashish Mittal, partner, M/s Legen Healthcare was discharged and complaint qua aforesaid accused was quashed (Page 231)(Annexure P-3).

::: Downloaded on - 09/07/2024 20:31:53 :::CIS 5

8. Though after passing of judgment dated 16.9.2013, stay granted by this court in proceedings sought to be quashed, stood vacated, but .

yet proceedings in the complaint were not taken forth. It is only in the year 2021, notices were issued to other respondents including petitioners but the fact remains that till date, charge has not been framed.

9. Respondent State has filed reply to the present petition, pursuant to notices issued in the instant proceedings, wherein facts as have

10.

r to been noticed herein above, have not been disputed, rather stand admitted.

Precisely, the grouse of the petitioner, as has been highlighted in the present petition and further canvassed by Mr. Anand Sharma, learned senior counsel duly assisted by Mr. Karan Sharma, Advocate, appearing for the petitioners is that court concerned, while issuing process against the petitioners, failed to take note of the fact that the complaint filed by Drug Inspector concerned under relevant provisions of Act/Rules is not maintainable against petitioners, who happen to be Directors of M/s Generica India Limited, for the reason that aforesaid company was merely a stockiest/trader, at no point of time, had any hand in manufacturing of drug in question, rather, action could be taken against M/s Legen Healthcare, which otherwise is admitted to have manufactured the drug in question. While making this court peruse Section 19(3) of the Act, Mr. Sharma, learned senior counsel appearing for the petitioners, vehemently argued that a person, not being the manufacturer of a drug or cosmetic or his agent for the distribution ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 6 thereof, shall not be liable for contravention of S.18 (a)(i) if he proves that he acquired the drug or cosmetic from a duly licensed .

manufacturer, distributor or dealer thereof; that he did not know and could not, with reasonable diligence, have ascertained that the drug or cosmetic, in any way, contravened the provisions of that section; and that the drug or cosmetic, while in his possession was properly stored and remained in the same state as when he acquired it.

11. While referring to S.34 of the Act, Mr. Sharma, learned senior counsel further argued that where an offence under this Act has been committed by a company, every person, who, at the time the offence was committed, was in charge of and was responsible to the company for the conduct of the business of the company, as well as the company shall be deemed to be guilty of the offence and shall be liable to be proceeded against and punished accordingly. First Proviso to aforesaid Section provides that nothing contained in this sub-section shall render any such person liable to any punishment provided in this Act if he proves that the offence was committed without his knowledge or that he exercised all due diligence to prevent the commission of such offence.

Second proviso to S.34 provides that notwithstanding anything contained in sub-section (1), where an offence under this Act has been committed by a company and it is proved that the offence has been committed with the consent or connivance of, or is attributable to any neglect on the part of, any Director, Manager, Secretary or other officer of the company, such Director, Manager, Secretary or other officer shall also be deemed to be guilty of that offence and shall be liable to be ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 7 proceeded against and punished accordingly, but it shall be incumbent upon complainant to prove that persons as detailed in said provision of .

law, were responsible for day-to-day activities of that company, on the date, offence was occurred,

12. While making this court peruse the complaint, Mr. Sharma, learned senior counsel attempted to carve out a case that there is not a single word suggestive of the fact that petitioners being Directors of company concerned were responsible for day-to-day activities of company, rather for that purpose authorized person, Mr. Hem Raj Thakur, accused No.4 was appointed. Mr. Sharma, further submitted that as per information given by M/s Aar Kay Surgicals, Sujanpur, to whom drug was sold by M/s Generica India Limited had specifically apprised Drug Inspector concerned that the drug was purchased from authorized representative Mr. Hem Raj Thakur vide invoice No. GIO 2530 dated 21.10.2008. If it is so, there was no occasion, if any, for the Drug Inspector concerned to implead petitioners herein as accused.

13. Mr. Sharma, learned senior counsel further submitted that since company i.e. M/s Generica India Limited has not been arrayed as an accused, complaint having been filed by Drug Inspector concerned otherwise is bound to fail, in terms of specific provisions contained under S. 34, which mandate for impleadment of company as an accused, if there is violation of any provisions contained under the Act.

In support of aforesaid submissions Mr. Sharma, learned senior counsel invited attention of this court to various judgments which shall be referred to in the later part of order.

::: Downloaded on - 09/07/2024 20:31:53 :::CIS 8

14. Lastly, Mr.Sharma, learned senior counsel argued that since on account of non-compliance of various provisions as detailed herein .

above, prosecution case is bound to fail, no fruitful purpose would be served in case, complaint as well as consequent proceedings against the petitioners herein are allowed to sustain, rather, continuation of same, if permitted would cause great prejudice to the petitioners who would be unnecessarily subjected to ordeal of protracted trial, which otherwise is bound to fail.

15. To the contrary, Mr. Rajan Kahol, learned Additional Advocate General, while supporting the registration of complaint by Drug Inspector against the petitioners, vehemently argued that petitioners being Directors of M/s Generica India Limited, are liable and responsible for conduct of business of the company. He submitted that respondent No.5 Mr. Hem Raj Thakur, was merely an authorized representative of the company and petitioners, being Directors of the Company, are liable to be punished for the commission of offence punishable under S.27 of the Act. While referring to S. 19(3) of the Act, Mr. Rajan Kahol, learned Additional Advocate General argued that once, there is no denial to the fact that drug in question was stocked by the company concerned and same was not found to be of standard quality, petitioners being Directors of company have been rightly booked for deliberate contravention of the provisions contained under S.18 of the Act. Lastly, Mr. Kahol, learned Additional Advocate General submitted that petition under S. 482 CrPC is not maintainable, especially when complaint sought to be quashed is already fixed for ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 9 consideration on charge. He further submitted that there is overwhelming evidence on record suggestive of the fact that petitioners .

have contravened various provisions contained under the Act and as such, it would be too premature at this stage to conclude that no case, much less case under S. 18(a)(i) punishable under S.27(d) of the Act, is made out against petitioners.

16. I have heard learned counsel for the parties and perused material available on record.

17. Before ascertaining the genuineness and correctness of the submissions and counter submissions having been made by the learned counsel for the parties vis-à-vis prayer made in the instant petition, this Court deems it necessary to discuss/elaborate the scope and competence of this Court to quash the criminal proceedings while exercising power under Section 482 of Cr.PC.

18. A three-Judge Bench of the Hon'ble Apex Court in case titled State of Karnataka v. L. Muniswamy and others, 1977 (2) SCC 699, held that High Court while exercising power under Section 482 Cr.PC is entitled to quash the proceedings, if it comes to the conclusion that allowing the proceeding to continue would be an abuse of the process of the Court or that the ends of justice require that the proceeding ought to be quashed.

19. Subsequently, in case titled State of Haryana and others v.

Bhajan Lal and others, 1992 Supp (1) SCC 335, the Hon'ble Apex Court while elaborately discussing the scope and competence of High Court to quash criminal proceedings under Section 482 Cr.PC laid ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 10 down certain principles governing the jurisdiction of High Court to exercise its power. After passing of aforesaid judgment, issue with .

regard to exercise of power under Section 482 Cr.PC, again came to be considered by the Hon'ble Apex Court in case bearing Criminal Appeal No.577 of 2017 (arising out of SLP (CrL.) No. 287 of 2017) titled Vineet Kumar and Ors. v. State of U.P. and Anr., wherein it has been held that saving of the High Court's inherent powers, both in civil and criminal matters, is designed to achieve a salutary public purpose i.e. court

20.

r to proceedings ought not to be permitted to degenerate into a weapon of harassment or persecution.

The Hon'ble Apex Court in Prashant Bharti v. State (NCT of Delhi), (2013) 9 SCC 293, relying upon its earlier judgment titled as Rajiv Thapar and Ors v. Madan Lal Kapoor, (2013) 3 SCC 330, reiterated that High Court has inherent powers under Section 482 Cr.PC., to quash the proceedings against an accused, at the stage of issuing process, or at the stage of committal, or even at the stage of framing of charge, but such power must always be used with caution, care and circumspection. In the aforesaid judgment, the Hon'ble Apex Court concluded that while exercising its inherent jurisdiction under Section 482 of the Cr.PC, Court exercising such power must be fully satisfied that the material produced by the accused is such, that would lead to the conclusion, that his/their defence is based on sound, reasonable, and indubitable facts and the material adduced on record itself overrule the veracity of the allegations contained in the accusations levelled by the prosecution/complainant. Besides above, ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 11 the Hon'ble Apex Court further held that material relied upon by the accused should be such, as would persuade a reasonable person to .

dismiss and condemn the actual basis of the accusations as false. In such a situation, the judicial conscience of the High Court would persuade it to exercise its power under Section 482 of the Cr.P.C. to quash such criminal proceedings, for that would prevent abuse of process of the court, and secure the ends of justice. In the aforesaid judgment titled as Prashant Bharti v. State (NCT of Delhi), (2013) 9 SCC 293, the Hon'ble Apex Court has held as under:-

"22. The proposition of law, pertaining to quashing of criminal proceedings, initiated against an accused by a High Court under Section 482 of the Code of Criminal Procedure (hereinafter referred to as "the Cr.P.C.") has been dealt with by this Court in Rajiv Thapar & Ors. vs. Madan Lal Kapoor wherein this Court inter alia held as under: (2013) 3 SCC 330, paras 29-30)
29. The issue being examined in the instant case is the jurisdiction of the High Court under Section 482 of the Cr.P.C., if it chooses to quash the initiation of the prosecution against an accused, at the stage of issuing process, or at the stage of committal, or even at the stage of framing of charges. These are all stages before the commencement of the actual trial. The same parameters would naturally be available for later stages as well. The power vested in the High Court under Section 482 of the Cr.P.C., at the stages referred to hereinabove, would have far reaching consequences, inasmuch as, it would negate the prosecution's/complainant's case without allowing the prosecution/complainant to lead evidence. Such a determination must always be rendered with caution, care and circumspection. To invoke its inherent jurisdiction under Section 482 of the Cr.P.C. the High Court has to be fully satisfied, that the material ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 12 produced by the accused is such, that would lead to the conclusion, that his/their defence is based on sound, reasonable, and indubitable facts; the material produced is such, as would .
rule out and displace the assertions contained in the charges levelled against the accused; and the material produced is such, as would clearly reject and overrule the veracity of the allegations contained in the accusations levelled by the prosecution/complainant. It should be sufficient to rule out, reject and discard the accusations levelled by the prosecution/complainant, without the necessity of recording any evidence. For this the material relied upon by the defence should not have been refuted, or alternatively, cannot be justifiably refuted, being material of sterling and impeccable quality. The material relied upon by the accused should be such, as would persuade a reasonable person to dismiss and condemn the actual basis of the accusations as false. In such a situation, the judicial conscience of the High Court would persuade it to exercise its power under Section 482 of the Cr.P.C. to quash such criminal proceedings, for that would prevent abuse of process of the court, and secure the ends of justice.
30. Based on the factors canvassed in the foregoing paragraphs, we would delineate the following steps to determine the veracity of a prayer for quashing, raised by an accused by invoking the power vested in the High Court under Section 482 of the Cr.P.C.:-
30.1 Step one, whether the material relied upon by the accused is sound, reasonable, and indubitable, i.e., the material is of sterling and impeccable quality? 30.2 Step two, whether the material relied upon by the accused, would rule out the assertions contained in the charges levelled against the accused, i.e., the material is sufficient to reject and overrule the factual assertions contained in the complaint, i.e., the material is such, as would persuade a reasonable person to dismiss and condemn the factual basis of the accusations as false. 30.3 Step three, whether the material relied upon by the accused, has not been refuted by the ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 13 prosecution/complainant; and/or the material is such, that it cannot be justifiably refuted by the prosecution/complainant?
30.4 Step four, whether proceeding with the trial would .

result in an abuse of process of the court, and would not serve the ends of justice?

30.5 If the answer to all the steps is in the affirmative, judicial conscience of the High Court should persuade it to quash such criminal - proceedings, in exercise of power vested in it under Section 482 of the Cr.P.C. Such exercise of power, besides doing justice to the accused, would save precious court time, which would otherwise be wasted in holding such a trial (as well as, proceedings arising therefrom) specially when, it is clear that the same would not conclude in the conviction of the accused."

21. It is quite apparent from the bare perusal of aforesaid judgments passed by the Hon'ble Apex Court from time to time that where a criminal proceeding is manifestly attended with mala fide and/or where the proceeding is maliciously instituted with an ulterior motive for wreaking vengeance on the accused and with a view to spite him/her due to private and personal grudge, High Court while exercising power under Section 482 Cr.PC can proceed to quash the proceedings.

22. Recently, the Hon'ble Apex Court in case tilted Anand Kumar Mohatta and Anr. v. State (Government of NCT of Delhi) Department of Home and Anr, AIR 2019 SC 210, has held that abuse of process caused by FIR stands aggravated if the FIR has taken the form of a charge sheet after investigation and as such, the abuse of law or miscarriage of justice can be rectified by the court while exercising power under Section 482 Cr.PC. The relevant paras of the judgment are as under:

16. Even otherwise it must be remembered that the provision invoked by the accused before the High Court is Section 482 Cr.
::: Downloaded on - 09/07/2024 20:31:53 :::CIS 14

P.C and that this Court is hearing an appeal from an order under Section 482 of Cr.P.C. Section 482 of Cr.P.C reads as follows: -

"482. Saving of inherent power of the High Court.- Nothing .
in this Code shall be deemed to limit or affect the inherent powers of the High Court to make such orders as may be necessary to give effect to any order under this Code, or to prevent abuse of the process of any Court or otherwise to secure the ends of justice."

17. There is nothing in the words of this Section which restricts the exercise of the power of the Court to prevent the abuse of process of court or miscarriage of justice only to the stage of the FIR. It is settled principle of law that the High court can exercise jurisdiction under Section 482 of Cr.P.C even when the discharge application is pending with the trial court ( G. Sagar Suri and Anr. V. State of U.P. and Others, (2000) 2 SCC 636 (para 7), Umesh Kumar v. State of Andhra Pradesh and Anr.

(2013) 10 SCC 591 (para 20). Indeed, it would be a travesty to hold that proceedings initiated against a person can be interfered with at the stage of FIR but not if it has advanced, and the allegations have materialized into a charge sheet. On the contrary it could be said that the abuse of process caused by FIR stands aggravated if the FIR has taken the form of a charge sheet after investigation. The power is undoubtedly conferred to prevent abuse of process of power of any court."

23. Recently, the Hon'ble Apex Court in case titled Pramod Suryabhan Pawar v. The State of Maharashtra and Anr, (2019) 9 SCC 608, has elaborated the scope of exercise of power under Section 482 Cr.PC, the relevant para whereof reads as under:-

"7. Section 482 is an overriding section which saves the inherent powers of the court to advance the cause of justice. Under Section 482 the inherent jurisdiction of the court can be exercised (i) to give effect to an order under the CrPC; (ii) to prevent the abuse of the process of the court; and (iii) to otherwise secure the ends of ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 15 justice. The powers of the court under Section 482 are wide and the court is vested with a significant amount of discretion to decide whether or not to exercise them. The court should be guarded in .
the use of its extraordinary jurisdiction to quash an FIR or criminal proceeding as it denies the prosecution the opportunity to establish its case through investigation and evidence. These principles have been consistently followed and re-iterated by this Court. In Inder Mohan Goswami v State of Uttaranchal5, this Court observed.
"23. This Court in a number of cases has laid down the scope and ambit of courts' powers under Section 482 CrPC. Every High Court has inherent powers to act ex debito justitiae to do real and substantial justice, for the administration of which alone it exists, or to prevent abuse of the process of the court. Inherent power under Section 482 CrPC can be exercised:
(i) to give effect to an order under the Code;
(ii) to prevent abuse of the process of the court, and
(iii) to otherwise secure the ends of justice.

24. Inherent powers under Section 482 CrPC though wide have to be exercised sparingly, carefully and with great caution and only when exercise is justified by the tests specifically laid down in this section itself. Authority of the court exists for the advancement of justice. If any abuse of the process leading to injustice is brought to the notice of the court, then the court would be justified in preventing injustice by invoking inherent powers in absence of specific provisions in the statute."

8. Given the varied nature of cases that come before the High Courts, any strict test as to when the court's extraordinary powers can be exercised is likely to tie the court's hands in the face of future injustices. This Court in State of Haryana v Bhajan Lal6 conducted a detailed study of the situations where the court may exercise its extraordinary jurisdiction and laid down a list of illustrative examples of where quashing may be appropriate. It is ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 16 not necessary to discuss all the examples, but a few bear relevance to the present case. The court in Bhajan Lal noted that quashing may be appropriate where, (2007) 12 SCC 1 1992 Supp .

(1) SCC 335 "102. (1) Where the allegations made in the first information report or the complaint, even if they are taken at their face value and accepted in their entirety do not prima facie constitute any offence or make out a case against the accused.

(2) Where the allegations in the first information report and other materials, if any, accompanying the FIR do not disclose a cognizable offence, justifying an investigation by police officers under Section 156(1) of the Code except under an order of a Magistrate within the purview of Section 155(2). ..........

(7) Where a criminal proceeding is manifestly attended with mala fide and/or where the proceeding is maliciously instituted with an ulterior motive for wreaking vengeance on the accused and with a view to spite him due to private and personal grudge."

In deciding whether to exercise its jurisdiction under Section 482, the Court does not adjudicate upon the veracity of the facts alleged or enter into an appreciation of competing evidence presented. The limited question is whether on the face of the FIR, the allegations constitute a cognizable offence. As this Court noted in Dhruvaram Murlidhar Sonar v State of Maharashtra, 2018 SCC OnLine SC3100 ("Dhruvaram Sonar") :

"13. It is clear that for quashing proceedings, meticulous analysis of factum of taking cognizance of an offence by the Magistrate is not called for. Appreciation of evidence is also not permissible in exercise of inherent powers. If the allegations set out in the complaint do not constitute the offence of which cognizance has been taken, it is open to the High Court to quash the same in exercise of its inherent powers."

24. Aforesaid law, clearly stipulates that court can exercise power under S.482 of the Code of Criminal Procedure, to quash criminal ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 17 proceedings, in cases, where the allegations made in the first information report or the complaint, even if they are taken at their face .

value and accepted in their entirety do not prima facie constitute any offence or make out a case against the accused.

25. Now being guided by the aforesaid proposition of law laid down by the Hon'ble Apex Court, this Court would make an endeavor to examine and consider the prayer made in the instant petition vis-à-vis factual matrix of the case.

26. Admittedly in the case at hand, drug in question i.e. Chlorpheniramine Maleate was not manufactured by M/s Generica India Limited, rather the same was manufactured by M/s Legen Healthcare. Petitioners herein have been arrayed as accused on account of their being Directors of M/sGenerica India Limited, which is admittedly a stockiest/trader of the drug in question. Sample of drug was drawn from pharmacy namely M/s Shri Shri Medical Store, whose in-charge was respondent No.2 Anil Chand. Above named Anil Chand disclosed to Drug Inspector concerned that the drug in question was purchased from M/s Aar Kay Surgicals, Sujanpur vide invoice dated 23.12.2008. M/s Aar Kay Surgicals, Sujanpur further informed the Drug Inspector concerned that the drug was purchased by it from M/s Generica India Limited vide invoice dated 21.10.2008 from Mr. Hem Raj Thakur, authorized representative M/s Generica India Limited.

Aforesaid private limited company, while responding to notice issued by Drug Inspector concerned, specifically disclosed that it is not the manufacturer of drug in question, rather it has purchased the same ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 18 from M/s Legen Healthcare and thereafter, being stockiest and trader, supplied the drug in question to whole seller M/s Aar Kay Surgicals, .

Sujanpur.

27. It is not in dispute that as per mandate of S.18, requisite information was made available by M/s Generica India Limited. M/s Generica India Limited specifically informed Drug Inspector concerned that the company concerned has appointed Mr. Hem Raj Thakur as its authorized signatory, enabling him to perform the day-to-day business of company (resolution passed by the company in this regard is available at page 56 of paper book). Complaint sought to be quashed came to be instituted under S.18(a)(i) of the Act and Rules framed under the Act, punishable under S.27(d) of the Act.

28. At this stage, it would be apt to take note of Section 18a(i) of Act, 1940, which reads as under:

18. Prohibition of manufacture and sale of certain drugs and cosmetics.--From such date as may be fixed by the State Government by notification in the Official Gazette in this behalf, no person shall himself or by any other person on his behalf--
(a) [manufacture for sale or for distribution, or sell, or stock or exhibit or offer for sale,] or distribute--

[(i) any drug which is not of a standard quality, or is misbranded, adulterated or spurious;

[(ii) any cosmetic which is not of a standard quality or is misbranded, adulterated or spurious;]] [(iii) any patent or proprietary medicine, unless there is displayed in the prescribed manner on the label or container thereof [the true formula or list of active ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 19 ingredients contained in it together with the quantities thereof];]

(iv) any drug which by means of any statement design or .

device accompanying it or by any other means, purports or claims [to prevent, cure or mitigate] any such disease or ailment, or to have any such other effect as may be prescribed;

[(v) any cosmetic containing any ingredient which may render it unsafe or harmful for use under the directions indicated or recommended;

(vi) any drug or cosmetic in contravention of any of the provisions of this Chapter or any rule made thereunder;]

(b) [sell or stock or exhibit or offer for sale,] or distribute any drug 9 [or cosmetic] which has been been imported or manufacutred in contravention of any of the provisions of this Act or any rule made thereunder;

(c) [manufacture for sale or for distribution, or sell, or stock or exhibit or offer for sale,] or distribute any drug [or cosmetic], except under, and in accordance with the conditions of, a licence issued for such purpose under this Chapter:

Provided that nothing in this section shall apply to the manufacture, subject to prescribed conditions, of small quantities of any drug for the purpose of examination, test or analysis :
Provided further that the [Central Government] may, after consultation with the Board, by notification in the Official Gazette, permit, subject to any conditions specified in the notifica tion, the [manufacture for sale or for distribution, sale, stocking or exhibiting or offering for sale] or distribution of any drug or class of drugs not being of standard quality.
::: Downloaded on - 09/07/2024 20:31:53 :::CIS 20

29. Perusal of afore provision of law makes it clear that no person can manufacture for sale or for distribution, or sell, or stock or exhibit or .

offer for sale or distribute any drug or cosmetic, which is not of standard quality or is misbranded, adulterous or spurious. Violation, if any, of aforesaid provision of law, would render person concerned, liable for punishment under Section 27 of the Act, which provides for penalty.

30. Admittedly, in the case at hand, drug in question which was supplied to M/s Aar Kay Surgicals by M/s Generica India Limited, was found to be of sub-standard quality as per Adverse Analysis Report given by CTL, Kandaghat and as such, no illegally can be said to have been committed by Drug Inspector, while instituting complaint, for commission of offence punishable under S.18(a)(i) punishable under S.27(d) of the Act, against the accused named in the complaint, including petitioners being Directors of M/s Generica India Limited but the question which needs determination at this stage is, "whether case made out against the petitioners herein, being Directors of M/s Generica India Limited under S. 18(a)(i) of Act is sustainable on account of certain immunities granted under S.19(3) of the Act or not?.

S.19(3) reads as under:

"19. Pleas.--(1)x x x x (2) x x x x (3) A person, not being the manufacturer of a drug or cosmetic or his agent for the distribution thereof, shall not be liable for a contravention of section 18 if he proves--
(a) that he acquired the drug or cosmetic from a duly licensed manufacturer, distributor or dealer thereof;
::: Downloaded on - 09/07/2024 20:31:53 :::CIS 21
(b) that he did not know and could not, with reasonable diligence, have ascertained that the drug or cosmetic in any way contravened the provisions of that section; and .
(c) that the drug or cosmetic, while in his possession, was properly stored and remained in the same state as when he acquired it."

31. Aforesaid provisions of S.19(3) categorically provide that a person, not being the manufacturer of a drug or cosmetic or his agent for the distribution thereof, shall not be liable for a contravention of S.18 if he proves (a) that he acquired the drug or cosmetic from a duly licensed manufacturer, distributor or dealer thereof; (b) that he did not know and could not, with reasonable diligence, have ascertained that the drug or cosmetic in any way contravened the provisions of that section; and (c) that the drug or cosmetic, while in his possession, was properly stored and remained in the same state as when he acquired it.

32. In the instant case, M/s Legen Healthcare, manufacturer of drug in question neither claimed before authority concerned, that drug in question was not supplied to M/s Generica India Limited or that the same was not properly stored by M/s Generica India Limited rather, M/s Legen Healthcare, while responding to notice issued by Drug Inspector concerned, admitted factum of its having manufactured the drug in question and its supply to M/s Generica India Limited under proper invoice. If the reply given by M/s Legen Healthcare to Drug Inspector concerned is perused, it specifically laid challenge to the report of CTL Kandaghat and requested to send second sample of drug in question to Central Drug Laboratory, for re-testing. Needless to say as per ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 22 procedure, company concerned can apply for re-testing of sample, but with the permission of Magistrate concerned.

.

33. No doubt, on account of report of CTL Kandaghat, case if any, is made out under S.18(a)(i) punishable under S.27(d) of the Act, against the manufacturer, stockiest, and the trader but since stockiest/trader can claim immunity from action under S. 18 of the Act, subject to satisfaction of conditions contained under S.19(3), there appears to be merit in the contention of Mr.Sharma, learned senior counsel appearing for the petitioners, that, once there is an admission on the part of M/s Legen Healthcare, manufacturer of drug, that the same was sold to M/s Generica India Limited under proper invoice and it had no knowledge that the drug has contravened provisions of S.18 coupled with the fact that there is nothing on record to suggest that the drug was not properly stored, after its acquisition from manufacturer, case if any under S.18 would not succeed in the competent court of law.

34. It also emerges from the record that on the date of receipt of notice from Drug Inspector concerned, stock of the drug in question stood sold out, as is evident from communication dated 23.12.2009 (page 136 of paper book) (Annexure PM).

35. Apart from above, this court finds that Drug Inspector concerned, while initiating proceedings against various accused named in the complaint, failed to implead M/s Generica India Limited as an accused.

If it is so, prosecution, if any, against petitioners being Directors of company is bound to fail, especially when nothing has been adduced on record to suggest that, on the date of drawing sample, petitioners ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 23 being directors of company were responsible for day-to-day affairs of company.

.

36. At this stage, it would be apt to take note of S. 34 of the unamended Act, 1940, which reads as under:

"34. Offences by companies.--
(1) Where an offence under this Act has been committed by a company, every person who at the time the offence was committed, was in charge of and was responsible to the company for the conduct of the business of the company, as well as the company shall be deemed to be guilty of the offence and shall be liable to be proceeded against and punished accordingly:
Provided that nothing contained in this sub-section shall render any such person liable to any punishment provided in this Act if he proves that the offence was committed without his knowledge or that he exercised all due diligence to prevent the commission of such offence.
(2) Notwithstanding anything contained in sub-section (1), where an offence under this Act has been committed by a company and it is proved that the offence has been committed with the consent or connivance of, or is attributable to any neglect on the part of, any director, manager, secretary or other officer of the company, such director, manager, secretary or other officer shall also be deemed to be guilty of that offence and shall be liable to be proceeded against and punished accordingly.
Explanation.--For the purposes of this section--
(a) "company" means a body corporate, and includes a firm or other association of individuals; and
(b) "director" in relation to a firm means a partner in the firm."

37. Aforesaid provision of law deals with offence, if any, committed by company. Aforesaid provision provides that where an offence under ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 24 this Act has been committed by a company, every person who at the time the offence was committed, was in charge of and was responsible .

to the company for the conduct of the business of the company, as well as the company shall be deemed to be guilty of the offence and shall be liable to be proceeded against and punished accordingly.

38. Proviso to the aforesaid section provides that nothing contained in this sub-section shall render any such person liable to any punishment provided in this Act if he proves that the offence was

39.

r to committed without his knowledge or that he exercised all due diligence to prevent the commission of such offence Till the time, company is arrayed as an accused, offence, if any, committed by company, cannot be ascertained. For the offence, if any, committed by a company, person responsible for conduct of business of the company is to be dealt in accordance with law, but admittedly, for doing so, such company is essentially required to be impleaded as accused. However, in the instant case, M/s Generica India Limited has not been arrayed as party till date. Since aforesaid company has not been arrayed as accused, it is not understood how prosecution would prove case against its Directors i.e. petitioners herein.

40. Reliance in this regard is placed upon a judgment rendered by Hon'ble Apex Court in Aneeta Hada v. Godfather Travels & Tours (P) Ltd., (2012) 5 SCC 661, wherein, a similar provision enacted in the Negotiable Instruments Act was considered by the Hon'ble Supreme Court and it was held that prosecution of the company is sine qua non for prosecuting the officials of the company. It is not permissible to ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 25 prosecute the officials without prosecuting the company. It was observed:-

.
"58. Applying the doctrine of strict construction, we are of the considered opinion that the commission of an offence by the company is an express condition precedent to attract the vicarious liability of others. Thus, the words "as well as the company" appearing in the section make it absolutely unmistakably clear that when the company can be prosecuted, then only the persons mentioned in the other categories could be vicariously liable for the offence subject to the averments in the petition and proof thereof. One cannot be oblivious of the fact that the company is a juristic person and it has its own respectability. If a finding is recorded against it, it would create a concavity in its reputation. There can be situations when the corporate reputation is affected when a Director is indicted.
59. In view of our aforesaid analysis, we arrive at the irresistible conclusion that for maintaining the prosecution under Section 141 of the Act, arraigning of a company as an accused is imperative. The other categories of offenders can only be brought in the dragnet on the touchstone of vicarious liability as the same has been stipulated in the provision itself. We say so on the basis of the ratio laid down in C.V. Parekh [(1970) 3 SCC 491: 1971 SCC (Cri) 97] which is a three-judge Bench decision. Thus, the view expressed in Sheoratan Agarwal [(1984) 4 SCC 352: 1984 SCC (Cri) 620] does not correctly lay down the law and, accordingly, is hereby overruled. The decision in Anil Hada [(2000) 1 SCC 1: 2001 SCC (Cri) 174] is overruled with the qualifier as stated in para 51. The decision in Modi Distillery [(1987) 3 SCC 684: 1987 SCC (Cri) 632] has to be treated to be restricted to its own facts as has been explained by us hereinabove.

41. A similar view was taken by Hon'ble Apex Court in Dayle De'souza v. Govt. of India, 2021 SCC OnLine SC 1012, wherein it was observed:-

"24. There is yet another difficulty for the prosecution in the present case as the Company has not been made an accused or even summoned to be tried for the offence. The position of law as propounded in State of Madras v. C.V. Parekh (1970) 3 SCC 491, reads:
"3. Learned Counsel for the appellant, however, sought conviction of the two respondents on the basis of Section 10 of the Essential Commodities Act under which, if the person contravening an order made under Section 3 (which covers an order under the Iron and Steel Control Order, 1956), is a company, every person who, at the time the contravention was committed, was in charge of, and was responsible to, the company for the conduct of the business of the company as well as the company, shall be deemed to be guilty of the contravention and shall be liable to be proceeded against and ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 26 punished accordingly. It was urged that the two respondents were in charge of, and were responsible to, the Company for the conduct of the business of the Company and, consequently, they must be held responsible for the sale and for thus contravening the provisions of clause (5) of the Iron and Steel .
Control Order. This argument cannot be accepted, because it ignores the first condition for the applicability of Section 10 to the effect that the person contravening the order must be a company itself. In the present case, there is no finding either by the Magistrate or by the High Court that the sale in contravention of clause (5) of the Iron and Steel Control Order was made by the Company. In fact, the Company was not charged with the offence at all. The liability of the persons in charge of the Company only arises when the contravention is by the Company itself. Since, in this case, there is no evidence and no finding that the Company contravened clause (5) of the Iron and Steel Control Order, the two respondents could not be held responsible. The actual contravention was by Kamdar and Vallabhdas Thacker and any contravention by them would not fasten responsibility on the respondents. The acquittal of the respondents is, therefore, fully justified. The appeal fails and is dismissed."

25. However, this proposition was later deviated from in Sheoratan Agarwal v. State of Madhya Pradesh (1984) 4 SCC 352. This case pertained to the pari materia provision under Section 10 of the Essential Commodities Act, 1955. The court held that anyone among the company itself; every person in charge of and responsible to the company for the conduct of the business; or any director, manager, secretary or other officers of the company with whose consent or connivance or because of whose neglect offence had been committed, could be prosecuted alone. However, the person in charge or an officer of the company could be held guilty in that capacity only after it has been established that there has been a contravention by the company as well. However, this will not mean that the person in charge or an officer of the company must be arraigned simultaneously along with the company if he is to be found guilty and punished.

26. Relying upon the reasoning in Sheoratan Agarwal (supra) and limiting the interpretation of C.V. Parekh (supra), this Court in Anil Hada v. Indian Acrylic Ltd. (2000) 1 SCC 1 had held that:

"13. If the offence was committed by a company it can be punished only if the company is prosecuted. But instead of prosecuting the company if a payee opts to prosecute only the persons falling within the second or third category, the payee can succeed in the case only if he succeeds in showing that the offence was actually committed by the company. In such a prosecution the accused can show that the company has not committed the offence, though such a company is not made an accused, and hence the prosecuted accused is not liable to be punished. The provisions do not contain a condition that prosecution of the company is sine qua non for prosecution of the other persons who fall within the second and the third categories ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 27 mentioned above. No doubt a finding that the offence was committed by the company is sine qua non for convicting those other persons. But if a company is not prosecuted due to any legal snag or otherwise, the other prosecuted persons cannot, on that score alone, escape from the penal liability created through the legal fiction envisaged in Section 141 .
of the Act."

27. However, subsequent decisions of this Court have emphasised that the provision imposes vicarious liability by way of deeming fiction which presupposes and requires the commission of the offence by the company itself as it is a separate juristic entity. Therefore, unless the company as a principal accused has committed the offence, the persons mentioned in sub- section (1) would not be liable and cannot be prosecuted. Section 141(1) of the Negotiable Instruments Act, extends vicarious criminal liability to the officers of a company by deeming fiction, which arises only when the offence is committed by the company itself and not otherwise. Overruling Sheoratan Agarwal and Anil Hada, in Aneeta Hada v. Godfather Travels and Tours Private Limited (2012)5 SCC 661, a 3-judge bench of this court expounding on the vicarious liability under Section 141 of the Negotiable Instruments Act, has held:

"51. We have already opined that the decision in Sheoratan Agarwal runs counter to the ratio laid down in C.V. Parekh which is by a larger Bench and hence, is a binding precedent. On the aforesaid ratiocination, the decision in Anil Hada has to be treated as not laying down the correct law as far as it states that the Director or any other officer can be prosecuted without impleadment of the company. Needless to emphasise, the matter would stand on a different footing where there is some legal impediment and the doctrine of lex non cogit ad impossibilia gets attracted.
xxxxxxxx
59. In view of our aforesaid analysis, we arrive at the irresistible conclusion that for maintaining the prosecution under Section 141 of the Act, arraigning of a company as an accused is imperative. The other categories of offenders can only be brought in the drag-net on the touchstone of vicarious liability as the same has been stipulated in the provision itself. We say so on the basis of the ratio laid down in C.V. Parekh which is a three-judge Bench decision. Thus, the view expressed in Sheoratan Agarwal does not correctly lay down the law and, accordingly, is hereby overruled. The decision in Anil Hada is overruled with the qualifier as stated in para 51. The decision in Modi Distillery has to be ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 28 treated to be restricted to its own facts as has been explained by us hereinabove."

42. From the aforesaid exposition of law laid down by Hon'ble Apex .

Court, it is thus clear that, a company, being a juristic person, cannot be imprisoned, but it can be subjected to a fine, which in itself is a punishment. Every punishment has adverse consequences, and therefore, prosecution of the company is mandatory. The exception would possibly be when the company itself has ceased to exist or cannot be prosecuted due to a statutory bar. However, such exceptions are of no relevance in the present case. Thus, the present prosecution must fail for this reason as well. Therefore, it is not permissible to prosecute the petitioners without prosecuting the company. Since the company has not been arrayed as an accused, therefore, it is not permissible to prosecute the petitioners, being Directors of the Company, in view of the binding precedents of the Hon'ble Supreme Court.

43. Reliance is also placed upon judgment rendered by Hon'ble Apex Court in Lalankumar Singh v. State of Maharashtra, 2022 (Supp.) Shim. LC 260, wherein, Hon'ble Apex Court held as under:

"14. It could thus be seen that this Court had held that simply because a person is a director of the company, it does not necessarily mean that he fulfils the twin requirements of Section 34(1) of the said Act so as to make him liable. It has been held that a person cannot be made liable unless, at the material time, he was incharge of and was also responsible to the company for the conduct of its business.
::: Downloaded on - 09/07/2024 20:31:53 :::CIS 29
15. In the case of S.M.S. Pharmaceuticals Ltd. vs. Neeta Bhalla and another, this Court was considering the question as to whether it was sufficient to make the person liable for being a director .
of a company under Section 141 of the negotiable Instruments Act, 1881. This Court considered the definition of the word "director" as defined in Section 2(13) of the Companies Act, 1956. This Court observed thus:
"8. ....... There is nothing which suggests that simply by being a director in a company, one is supposed to discharge particular functions on behalf of a company. It happens that a person may be a director in a company but he may not know anything about the daytoday functioning of the company. As a director he may be attending meetings of the Board of Directors of the company where usually they decide policy matters and guide the course of business of a company. It may be that a Board of Directors may appoint subcommittees consisting of one or two directors out of the Board of the company who may be made responsible for the daytoday functions of the company. These are 4 (2005) 8 SCC 89 matters which form part of resolutions of the Board of Directors of a company.
Nothing is oral. What emerges from this is that the role of a director in a company is a question of fact depending on the peculiar facts in each case. There is no universal rule that a director of a company is in charge of its everyday affairs. We have discussed about the position of a director in a company in order to illustrate the point that there is no magic as such in a particular word, be it director, manager or secretary. It all depends upon the respective roles assigned to the officers in a company. ....."

16. It was held that merely because a person is a director of a company, it is not necessary that he is aware about the daytoday functioning of the company. This Court held that there is no universal rule that a director of a company is in charge of its everyday affairs. It was, therefore, necessary, to aver as to how the director of the company was in charge of daytoday affairs of the company or responsible to the affairs of the company. This Court, however, clarified that the position of a managing director or a joint managing director in a company may be different. This Court further held that these persons, as the designation of their office suggests, are in charge of a company and are responsible for the conduct of the business of the company. To escape liability, they will have to prove that when the offence was committed, they had no knowledge of the ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 30 offence or that they exercised all due diligence to prevent the commission of the offence.

17. In the case of Pooja Ravinder Devidasani vs. State of .

Maharashtra and another this Court observed thus:

"17. ...... Every person connected with the Company will not fall into the ambit of the provision. Time and again, it has been asserted by this Court that only those persons who were in charge of and responsible for the conduct of the business of the Company at the time of commission of an offence will be liable for criminal action. A Director, who was not in charge of and was not responsible for the conduct of the business of the Company at the relevant time, will not be liable for an offence under Section 141 of the NI Act. In National Small Industries Corpn. [National Small Industries Corpn. Ltd. v. Harmeet Singh Paintal, (2010) 3 SCC 330 : (2010) 1 SCC (Civ) 677 : (2010) 2 SCC (Cri) 1113] this Court observed: (SCC p. 336, paras 1314) 5 (2014) 16 SCC 1 "13. Section 141 is a penal provision creating vicarious liability, and which, as per settled law, must be strictly construed. It is therefore, not sufficient to make a bald cursory statement in a complaint that the Director (arrayed as an accused) is in charge of and responsible to the company for the conduct of the business of the company without anything more as to the role of the Director. But the complaint should spell out as to how and in what manner Respondent 1 was in charge of or was responsible to the accused Company for the conduct of its business. This is in consonance with strict interpretation of penal statutes, especially, where such statutes create vicarious liability.
14. A company may have a number of Directors and to make any or all the Directors as accused in a complaint merely on the basis of a statement that they are in charge of and responsible for the conduct of the business of the company without anything more is not a sufficient or adequate fulfilment of the requirements under Section 141." (emphasis in original)

18. In Girdhari Lal Gupta v. D.H. Mehta [Girdhari Lal Gupta v. D.H. Mehta, (1971) 3 SCC 189 : 1971 SCC (Cri) 279 :AIR 1971 SC 2162], this Court observed that a person "in charge of a business"

means that the person should be in overall control of the daytoday business of the Company."

44. There is another aspect of the matter, that once there is no dispute qua the fact, that M/s Generica India Limited had appointed Mr. ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 31 Hem Raj Thakur as its authorized signatory, as is evident from Annexure P-1, (para 8 of complaint) and he was otherwise responsible .

for day-to-day functions of the company, there was otherwise no occasion, if any, for Drug Inspector concerned to implead petitioners, being Directors of company as accused.

45. Once, Mr. Hem Raj Thakur being authorized signatory was responsible for conduct of business of firm in question and invoice, vide which drug was sold to M/s Aar Kay Surgicals Sujanpur, contained his signatures, coupled with the fact that no material came to be adduced on record qua the fact that petitioners, being Directors of M/s Generica India Limited were looking after day-to-day affairs of the company, no case, if any, under S.18(a)(i), punishable under S.27(d) of the Act could be registered against petitioners being Directors of company

46. This court in similar circumstances, where company was not arrayed as an accused, straightway proceeded to quash the proceedings, vide order dated 16.9.2023 passed in CrMMO No. 111 of 2013, titled Ashish Mittal v. State of Himachal Pradesh, relevant paras whereof read as under:

"11. A similar proposition was dealt with by the Apex Court in Aneeta Hada v. Godhfather Travels and Tours Private Limited, (2012) 5 SCC 661, while dealing with Section 141 of the Negotiable Instruments Act quoted above, held that when a person, which is a Company commits an offence, then certain categories of persons incharge as well as the Company would be deemed to be liable for the offences under Section 138 of the Negotiable Instruments Act. Thus, the statutory intendment is absolutely plain. The provision makes the functionaries and the Companies/ firms liable and that is by deeming fiction, which has its own significance.
::: Downloaded on - 09/07/2024 20:31:53 :::CIS 32
12. Also on the comparative reading of the above Sections under the different statutes, it can safely be concluded that every person connected with Company shall not fall within the ambit of Section 34 .

of the Act, which has a marked similarity with the similar provisions of Negotiable Instruments Act. The conclusion is obvious that only those persons, who are incharge of and responsible for the conduct of the business of the Company at the time of commission of the offence are liable for the criminal action. The explanation added to Section 34 ibid shows that the Company means a body corporate and includes a firm or other association of individuals and Directos in relation to a firm means a Partner.

13. In the instant case, the petitioner is alleged to be a Partner of "M/s. Legen Healthcare". The said firm has not been impleaded as an accused and also there is no allegation in the complaint that the petitioner in the capacity as a Partner was incharge of and responsible for the conduct-business of the said firm. Therefore, in my opinion, summoning of the petitioner for the alleged offence in his capacity as a Partner is wrong and illegal.

14. Thus, the logical conclusion is that the summoning of the petitioner as a Partner of the said firm as an accused is unsustainable, hence, quashed and set aside., but, however, it shall open to the Drug Inspector to implead the Company as an accused by moving an appropriate application before the learned trial Court and in case there is any evidence during the trial that a particular person is incharge of or responsible for the conduct of the business or the Company including the petitioner, he can also be impleaded as an accused. The record of learned trial Court be returned forthwith and shall reach before it on or before 21.10.2013."

47. In the aforesaid judgment, Coordinate Bench of this Court, having taken note of the fact that the firm, of which petitioner in that case was a partner, was not impleaded as an accused, coupled with the fact that there was no allegation against the petitioner, being partner ::: Downloaded on - 09/07/2024 20:31:53 :::CIS 33 or in charge or responsible for conduct of business of said firm, held summoning of petitioner in that case bad in law.

.

48. Similar is present case. In the instant case, though petitioners being Directors of company have been arrayed as accused, but the company namely, M/s Generica India Limited has not been arrayed as accused, as such, prosecution of the petitioners alone, is bound to fail.

Most importantly, protection under S.19(3) of Act is also available to petitioners being stockiest/traders, for the reason that sale of drug in question by manufacture to M/s Generica India Limited has not been denied by M/s Legen Healthcare, the admitted manufacturer of drug. It clearly emerges from the complaint that M/s Generica India Limited being duly licenced stockiest, purchased drug from duly licenced manufacturer and sold the same thereafter to M/s Aar Kay Surgicals, vide proper invoice dated 23.12.2008.

49. Having scanned the entire material adduced on record, vis-à-vis prayer made in the instant petition, this court is persuaded to agree with Mr. Anand Sharma, learned senior counsel, appearing for the petitioners, that this court, while exercising power under S.482 CrPC may proceed to quash the complaint against the petitioners, because continuance thereof would be sheer abuse of process of law, since, for the reasons stated herein above, case of prosecution is bound to fail against the petitioners in all probabilities.

50. Otherwise also, in case prayer made on behalf of the petitioners is not accepted they would be subjected to unnecessary ordeal of facing protracted trial, which otherwise is bound to fail.

::: Downloaded on - 09/07/2024 20:31:53 :::CIS 34

51. In view of detailed discussion made herein above and law taken into consideration, present petition is allowed. Complaint No. HFW-

.

HMR(PROS) DRUGS/10-09, registered as Complaint No. 58-1 of 2010 titled as State of Himachal Pradesh (through Drugs Inspector H.Q. Hamirpur) v. Anil Chand and others as well as consequent proceedings pending in the court of learned Judicial Magistrate First Class, Nadaun, Hamirpur (Annexure P-2) are quashed and set aside qua the petitioners. The petitioners are discharged henceforth. All pending r to applications, stand disposed of.

(Sandeep Sharma) Judge July 4, 2024 (vikrant) ::: Downloaded on - 09/07/2024 20:31:53 :::CIS